Journal
JOURNAL OF MEDICINAL CHEMISTRY
Volume 64, Issue 20, Pages 15402-15419Publisher
AMER CHEMICAL SOC
DOI: 10.1021/acs.jmedchem.1c01458
Keywords
-
Categories
Ask authors/readers for more resources
The study found 32 to be a potent and selective ASK1 inhibitor with suitable pharmacokinetic properties and brain penetration for preclinical studies in neurological diseases.
Apoptosis signal-regulating kinase 1 (ASK1) is one of the key mediators of the cellular stress response that regulates inflammation and apoptosis. To probe the therapeutic value of modulating this pathway in preclinical models of neurological disease, we further optimized the profile of our previously reported inhibitor 3. This effort led to the discovery of 32, a potent (cell IC50 = 25 nM) and selective ASK1 inhibitor with suitable pharmacokinetic and brain penetration (rat Cl/Cl-u = 1.6/56 L/h/kg and K-p,K- uu = 0.46) for proof-of-pharmacology studies. Specifically, the ability of 32 to inhibit ASK1 in the central nervous system (CNS) was evaluated in a human tau transgenic (Tg4510) mouse model exhibiting elevated brain inflammation. In this study, transgenic animals treated with 32 (at 3, 10, and 30 mg/kg, BID/PO for 4 days) showed a robust reduction of inflammatory markers (e.g., IL-1 beta) in the cortex, thus confirming inhibition of ASK1 in the CNS.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available